WHO to resume hydroxychloroquine trial after earlier halt over safety concerns

4 Jun, 2020

Questions raised over study claiming drug linked to higher rate of mortality and heart problems in Covid-19 patients

The World Health Organization will resume clinical trials of an anti-malaria drug researchers hope may treat Covid-19, after a study of the drug published in May by a major medical journal prompted them to halt trials due to safety concerns.

Click here for reference